Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Natus to Present at 30th Annual Roth Conference

Posted on: 05 Mar 18

PLEASANTON, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:BABY) today announced that Jim Hawkins, President and Chief Executive Officer will present and Jonathan Kennedy, Executive Vice-President and Chief Financial Officer will be in attendance at the 30th Annual Roth Conference in Dana Point, CA. Mr. Hawkins is scheduled to present on Monday, March 12th at 9:30 a.m. Pacific Time (12:30 p.m. ET).

Investors may listen to a live webcast and view a copy of the slide presentation online via the “Investors” section of the Company’s web site at The recorded webcast will be accessible online for at least 30 days.

About Natus Medical

Natus is a leading provider of healthcare products and services used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, neurosurgery, epilepsy, sleep disorders, and balance and mobility disorders.

Additional information about Natus Medical can be found at

Natus Medical Incorporated
Jonathan A. Kennedy
Executive Vice President Finance and Chief Financial Officer
(925) 223-6700


Last updated on: 05/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.